The effect of co‐administered flavonoids on the metabolism of hesperetin and the disposition of its metabolites in Caco‐2 cell monolayers
Identifieur interne : 001B56 ( Main/Exploration ); précédent : 001B55; suivant : 001B57The effect of co‐administered flavonoids on the metabolism of hesperetin and the disposition of its metabolites in Caco‐2 cell monolayers
Auteurs : Walter Brand [Pays-Bas, Suisse] ; Beatriz Padilla [Pays-Bas] ; Peter J. Van Bladeren [Pays-Bas, Suisse] ; Gary Williamson [Suisse, Royaume-Uni] ; Ivonne M. C. M. Rietjens [Pays-Bas]Source :
- Molecular Nutrition & Food Research [ 1613-4125 ] ; 2010-06.
English descriptors
- KwdEn :
Abstract
Metabolism by phase II enzymes and transport from intestinal cells back into the lumen by ATP binding cassette (ABC) transporters limits the bioavailability of the flavanone hesperetin, the aglycone of hesperidin. This study investigates to what extent other flavonoids modulate the metabolism and transport of hesperetin by characterizing the effect of co‐administrating a series of flavonoids using Caco‐2 cell monolayers in a two‐compartment transwell system. Flavonoids may interfere with hesperetin metabolism and can also inhibit the apically located ABC transporter breast cancer resistance protein (ABCG2) which was previously shown to be responsible for the apical transport of hesperetin metabolites. Co‐exposure of Caco‐2 cell monolayers to hesperetin with specific flavonoids reduced the ratio of apical efflux to basolateral transport of hesperetin metabolites, and in some cases, also reduced the amount of hesperetin metabolites detected extracellularly. As intracellular accumulation of hesperetin metabolites did not account for this decrease, inhibition of metabolism of hesperetin is likely the underlying mechanism for the reduced metabolite formation and excretion. In spite of the reduction in metabolism the amount of hesperetin metabolites transported to the basolateral side significantly increased upon co‐exposure with specific flavonoids and therefore co‐administration of specific flavonoids could be a strategy to improve the bioavailability of hesperetin.
Url:
DOI: 10.1002/mnfr.200900183
Affiliations:
- Pays-Bas, Royaume-Uni, Suisse
- Angleterre, Canton de Vaud, Gueldre (province), Yorkshire-et-Humber
- Lausanne, Leeds, Wageningue
- Université de Leeds, Université de Wageningue
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001928
- to stream Istex, to step Curation: 001927
- to stream Istex, to step Checkpoint: 000363
- to stream Main, to step Merge: 001B94
- to stream Main, to step Curation: 001B56
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The effect of co‐administered flavonoids on the metabolism of hesperetin and the disposition of its metabolites in Caco‐2 cell monolayers</title><author><name sortKey="Brand, Walter" sort="Brand, Walter" uniqKey="Brand W" first="Walter" last="Brand">Walter Brand</name></author><author><name sortKey="Padilla, Beatriz" sort="Padilla, Beatriz" uniqKey="Padilla B" first="Beatriz" last="Padilla">Beatriz Padilla</name></author><author><name sortKey="Van Bladeren, Peter J" sort="Van Bladeren, Peter J" uniqKey="Van Bladeren P" first="Peter J." last="Van Bladeren">Peter J. Van Bladeren</name></author><author><name sortKey="Williamson, Gary" sort="Williamson, Gary" uniqKey="Williamson G" first="Gary" last="Williamson">Gary Williamson</name></author><author><name sortKey="Rietjens, Ivonne M C M" sort="Rietjens, Ivonne M C M" uniqKey="Rietjens I" first="Ivonne M. C. M." last="Rietjens">Ivonne M. C. M. Rietjens</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C873EB044CA1BF214A665414EC1F0C4B2CF62986</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1002/mnfr.200900183</idno><idno type="url">https://api.istex.fr/document/C873EB044CA1BF214A665414EC1F0C4B2CF62986/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001928</idno><idno type="wicri:Area/Istex/Curation">001927</idno><idno type="wicri:Area/Istex/Checkpoint">000363</idno><idno type="wicri:doubleKey">1613-4125:2010:Brand W:the:effect:of</idno><idno type="wicri:Area/Main/Merge">001B94</idno><idno type="wicri:Area/Main/Curation">001B56</idno><idno type="wicri:Area/Main/Exploration">001B56</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The effect of co‐administered flavonoids on the metabolism of hesperetin and the disposition of its metabolites in Caco‐2 cell monolayers</title><author><name sortKey="Brand, Walter" sort="Brand, Walter" uniqKey="Brand W" first="Walter" last="Brand">Walter Brand</name><affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Division of Toxicology, Wageningen University, Wageningen</wicri:regionArea><orgName type="university">Université de Wageningue</orgName><placeName><settlement type="city">Wageningue</settlement><region nuts="2">Gueldre (province)</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Suisse</country><wicri:regionArea>Nestlé Research Center, Nestec Ltd., Lausanne</wicri:regionArea><placeName><settlement type="city">Lausanne</settlement><region nuts="3" type="region">Canton de Vaud</region></placeName></affiliation></author><author><name sortKey="Padilla, Beatriz" sort="Padilla, Beatriz" uniqKey="Padilla B" first="Beatriz" last="Padilla">Beatriz Padilla</name><affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Division of Toxicology, Wageningen University, Wageningen</wicri:regionArea><orgName type="university">Université de Wageningue</orgName><placeName><settlement type="city">Wageningue</settlement><region nuts="2">Gueldre (province)</region></placeName></affiliation></author><author><name sortKey="Van Bladeren, Peter J" sort="Van Bladeren, Peter J" uniqKey="Van Bladeren P" first="Peter J." last="Van Bladeren">Peter J. Van Bladeren</name><affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Division of Toxicology, Wageningen University, Wageningen</wicri:regionArea><orgName type="university">Université de Wageningue</orgName><placeName><settlement type="city">Wageningue</settlement><region nuts="2">Gueldre (province)</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Suisse</country><wicri:regionArea>Nestlé Research Center, Nestec Ltd., Lausanne</wicri:regionArea><placeName><settlement type="city">Lausanne</settlement><region nuts="3" type="region">Canton de Vaud</region></placeName></affiliation></author><author><name sortKey="Williamson, Gary" sort="Williamson, Gary" uniqKey="Williamson G" first="Gary" last="Williamson">Gary Williamson</name><affiliation wicri:level="3"><country xml:lang="fr">Suisse</country><wicri:regionArea>Nestlé Research Center, Nestec Ltd., Lausanne</wicri:regionArea><placeName><settlement type="city">Lausanne</settlement><region nuts="3" type="region">Canton de Vaud</region></placeName></affiliation><affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Food Science and Nutrition, University of Leeds, Leeds</wicri:regionArea><orgName type="university">Université de Leeds</orgName><placeName><settlement type="city">Leeds</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Yorkshire-et-Humber</region></placeName></affiliation></author><author><name sortKey="Rietjens, Ivonne M C M" sort="Rietjens, Ivonne M C M" uniqKey="Rietjens I" first="Ivonne M. C. M." last="Rietjens">Ivonne M. C. M. Rietjens</name><affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Division of Toxicology, Wageningen University, Wageningen</wicri:regionArea><orgName type="university">Université de Wageningue</orgName><placeName><settlement type="city">Wageningue</settlement><region nuts="2">Gueldre (province)</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Molecular Nutrition & Food Research</title><title level="j" type="abbrev">Mol. Nutr. Food Res.</title><idno type="ISSN">1613-4125</idno><idno type="eISSN">1613-4133</idno><imprint><publisher>WILEY‐VCH Verlag</publisher><pubPlace>Weinheim</pubPlace><date type="published" when="2010-06">2010-06</date><biblScope unit="volume">54</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="851">851</biblScope><biblScope unit="page" to="860">860</biblScope></imprint><idno type="ISSN">1613-4125</idno></series><idno type="istex">C873EB044CA1BF214A665414EC1F0C4B2CF62986</idno><idno type="DOI">10.1002/mnfr.200900183</idno><idno type="ArticleID">MNFR200900183</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1613-4125</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast cancer resistance protein</term><term>Hesperetin</term><term>In vitro bioavailability</term><term>Metabolism</term><term>Quercetin</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Metabolism by phase II enzymes and transport from intestinal cells back into the lumen by ATP binding cassette (ABC) transporters limits the bioavailability of the flavanone hesperetin, the aglycone of hesperidin. This study investigates to what extent other flavonoids modulate the metabolism and transport of hesperetin by characterizing the effect of co‐administrating a series of flavonoids using Caco‐2 cell monolayers in a two‐compartment transwell system. Flavonoids may interfere with hesperetin metabolism and can also inhibit the apically located ABC transporter breast cancer resistance protein (ABCG2) which was previously shown to be responsible for the apical transport of hesperetin metabolites. Co‐exposure of Caco‐2 cell monolayers to hesperetin with specific flavonoids reduced the ratio of apical efflux to basolateral transport of hesperetin metabolites, and in some cases, also reduced the amount of hesperetin metabolites detected extracellularly. As intracellular accumulation of hesperetin metabolites did not account for this decrease, inhibition of metabolism of hesperetin is likely the underlying mechanism for the reduced metabolite formation and excretion. In spite of the reduction in metabolism the amount of hesperetin metabolites transported to the basolateral side significantly increased upon co‐exposure with specific flavonoids and therefore co‐administration of specific flavonoids could be a strategy to improve the bioavailability of hesperetin.</div></front></TEI><affiliations><list><country><li>Pays-Bas</li><li>Royaume-Uni</li><li>Suisse</li></country><region><li>Angleterre</li><li>Canton de Vaud</li><li>Gueldre (province)</li><li>Yorkshire-et-Humber</li></region><settlement><li>Lausanne</li><li>Leeds</li><li>Wageningue</li></settlement><orgName><li>Université de Leeds</li><li>Université de Wageningue</li></orgName></list><tree><country name="Pays-Bas"><region name="Gueldre (province)"><name sortKey="Brand, Walter" sort="Brand, Walter" uniqKey="Brand W" first="Walter" last="Brand">Walter Brand</name></region><name sortKey="Padilla, Beatriz" sort="Padilla, Beatriz" uniqKey="Padilla B" first="Beatriz" last="Padilla">Beatriz Padilla</name><name sortKey="Rietjens, Ivonne M C M" sort="Rietjens, Ivonne M C M" uniqKey="Rietjens I" first="Ivonne M. C. M." last="Rietjens">Ivonne M. C. M. Rietjens</name><name sortKey="Van Bladeren, Peter J" sort="Van Bladeren, Peter J" uniqKey="Van Bladeren P" first="Peter J." last="Van Bladeren">Peter J. Van Bladeren</name></country><country name="Suisse"><region name="Canton de Vaud"><name sortKey="Brand, Walter" sort="Brand, Walter" uniqKey="Brand W" first="Walter" last="Brand">Walter Brand</name></region><name sortKey="Van Bladeren, Peter J" sort="Van Bladeren, Peter J" uniqKey="Van Bladeren P" first="Peter J." last="Van Bladeren">Peter J. Van Bladeren</name><name sortKey="Williamson, Gary" sort="Williamson, Gary" uniqKey="Williamson G" first="Gary" last="Williamson">Gary Williamson</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Williamson, Gary" sort="Williamson, Gary" uniqKey="Williamson G" first="Gary" last="Williamson">Gary Williamson</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/OrangerV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B56 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B56 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Bois
|area= OrangerV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:C873EB044CA1BF214A665414EC1F0C4B2CF62986
|texte= The effect of co‐administered flavonoids on the metabolism of hesperetin and the disposition of its metabolites in Caco‐2 cell monolayers
}}
| This area was generated with Dilib version V0.6.25. |  |